Capital Fund Management S.A. Invitae Corp Call Options Transaction History

Capital Fund Management S.A.

  • $36 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$2.13 - $9.01 $343,143 - $1.45 Million
-161,100 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$6.28 - $15.59 $1.01 Million - $2.51 Million
161,100 New
161,100 $1.28 Million
Q1 2021

May 14, 2021
SELL
$33.06 - $56.93 $641,364 - $1.1 Million
-19,400 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$39.09 - $57.4 $758,346 - $1.11 Million
19,400 New
19,400 $811,000

Others Institutions Holding NVTA

# of Institutions
21
Shares Held
1.92M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Capital Fund Management S.A. Portfolio

Follow Capital Fund Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email